Company Overview

British American Tobacco p.l.c. is a multinational consumer goods company operating primarily in the tobacco and nicotine products industry. The company develops, manufactures, and sells combustible cigarettes, smokeless tobacco, and a growing portfolio of non-combustible nicotine products. Its core revenue drivers remain traditional cigarettes, complemented by expanding contributions from reduced-risk products such as vaping, heated tobacco, and oral nicotine.

The company serves adult consumers across developed and emerging markets, with a strategic focus on brand-led growth and product innovation. British American Tobacco holds a strong competitive position through its global brand portfolio, extensive distribution network, and scale advantages in manufacturing and supply chain management. Founded in 1902 following the merger of British and American tobacco interests, the company has evolved through consolidation, geographic expansion, and diversification into next-generation nicotine products, most notably after the acquisition of Reynolds American Inc. in 2017.

Business Operations

British American Tobacco operates through multiple business segments centered on Combustible Tobacco and New Categories, which include vapor, tobacco heating products, and modern oral nicotine. Combustible cigarettes remain the largest revenue contributor, supported by global brands such as Dunhill, Kent, Lucky Strike, and Pall Mall. The New Categories segment is a strategic growth area, driven by products like Vuse (vapor), glo (heated tobacco), and Velo (oral nicotine).

Operations span both domestic and international markets, with manufacturing facilities, distribution centers, and supply chain operations across multiple continents. The company controls proprietary product technologies, brand intellectual property, and a vertically integrated tobacco supply chain. Key subsidiaries include BAT Investments Ltd. and Reynolds American Inc., with the latter serving as the primary operating entity in the United States. British American Tobacco also maintains long-term strategic relationships with suppliers and regulatory stakeholders to support market access and compliance.

Strategic Position & Investments

The company’s strategic direction emphasizes transitioning toward a “multi-category” nicotine business while continuing to manage and optimize its combustible portfolio. Growth initiatives focus on expanding the New Categories segment, increasing adult consumer adoption of reduced-risk products, and achieving profitability in these categories over the medium term. Capital allocation priorities include investment in innovation, brand development, and debt reduction following prior large-scale acquisitions.

British American Tobacco’s most significant historical investment remains the acquisition of Reynolds American Inc., which strengthened its position in the U.S. market and expanded its reduced-risk product capabilities. The company continues to invest in research and development related to nicotine science, product safety, and harm reduction, while selectively entering emerging nicotine formats and technologies aligned with evolving consumer preferences and regulatory frameworks.

Geographic Footprint

British American Tobacco operates in over 180 markets worldwide, with corporate headquarters in London, United Kingdom. The company has a strong presence across Europe, North America, Asia-Pacific, Latin America, and Africa and the Middle East, with particularly significant market positions in the United States, Western Europe, and several high-growth emerging economies.

Its global footprint includes manufacturing plants, leaf growing operations, and distribution networks across all major continents. International operations account for the majority of revenue, with the United States representing a substantial single-market exposure through Reynolds American Inc. The company’s geographic diversification helps balance regulatory, economic, and consumer demand risks across regions.

Leadership & Governance

British American Tobacco is led by an experienced executive team with a focus on long-term value creation, regulatory engagement, and transformation toward reduced-risk products. The leadership philosophy emphasizes responsible business practices, strong corporate governance, and a managed transition aligned with public health and sustainability considerations.

Key executives include:

• Tadeu Marroco – Chief Executive Officer
• Kingsley Wheaton – Chief Growth Officer
• Johan Vandermeulen – Chief Financial Officer
• Luc Jobin – Chair of the Board
• Marroco, Tadeu – Executive Director

The Board of Directors oversees strategy, risk management, and governance, with a structure designed to balance shareholder interests, regulatory obligations, and long-term strategic execution.